Lenacapavir is a new medication for preventing HIV. It is given as an injection once every six months, unlike daily pills. Experts believe it can greatly help in stopping new infections.
For lenacapavir to be effective, people need to afford it. If the price is low, many more people can use it. The goal is to provide this drug to one million people in low and middle-income countries in its first year.
Production must be strong and reliable so that everyone can access it, especially in places where healthcare is limited.
Difficult words
- medication — A substance used to treat or prevent illness.
- afford — To have enough money to pay for something.
- effective — Able to produce the desired result or effect.
- access — To be able to use or get something.
- production — The process of making something.
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How might cutting the price of lenacapavir affect access in different countries?
- Why is it important for production to be reliable?
- What challenges might arise in providing this medication to low-income countries?
Related articles
Social Media Fuelling Risky Bushmeat Sales – Study
A study shows that social media helps in the illegal sale of bushmeat in West Africa, increasing disease risks and threatening wildlife.
Can Noninvasive Nasal Drops Kill Deadly Brain Tumors?
Researchers have created a nose-delivered medicine that can eliminate dangerous brain tumors in mice.
Cholera Outbreak in Sudan
A cholera outbreak in Sudan has spread across all states, leading to thousands of cases and deaths amidst ongoing conflict and poor sanitary conditions.
New Antibody Test: Fast, No Blood Needed
A new test detects antibodies quickly without blood. It could help monitor infections and vaccine effectiveness.
Emory study: 2023–24 COVID vaccine gives lasting antibodies
Emory University measured antibody responses in 24 people after the 2023–24 monovalent vaccine targeting Omicron XBB.1.5. The study found long-lasting antibodies, cross-reactive protection with the ancestral WA1 strain, and a 2.8-fold boost from immune imprinting.
Pandemic Threat and Inequality
This article explains how inequality makes it harder to prevent pandemics, highlighting the cycle of disease and social disparity.